Antidepressant prescriptions in paediatric outpatients in Europe

Paediatric and Perinatal Drug Therapy

Volumn 8, Issue 3, 2007, Pages 103-108

  Clavenna, Antonio ^a   Bonati, Maurizio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Adolescent; Antidepressive agent; Child; Drug utilisation; Europe; General practice

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYPERICUM EXTRACT; IMIPRAMINE; MIRTAZAPINE; OPIPRAMOL; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VENLAFAXINE;

AREA UNDER THE CURVE; ARTICLE; CHILD PSYCHIATRY; COMPARATIVE STUDY; DENMARK; DRUG LEGISLATION; DRUG MONITORING; DRUG USE; EMBASE; EUROPE; FRANCE; GENDER BIAS; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; HYPERICUM; IRELAND; ITALY; MEDICAL LITERATURE; MEDLINE; NETHERLANDS; OUTPATIENT CARE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PREVALENCE; PROSPECTIVE STUDY; SPAIN; SYSTEMATIC REVIEW; UNITED KINGDOM; VALIDATION STUDY;

EID: 49749153503     PISSN: 14630095     EISSN: None     Source Type: Journal    
DOI: 10.1185/146300907X199911     Document Type: Article

References (39)

1. EMEA. European Medicines Agency finalises review of antidepressants in children and adolescents. Available at: http://www.emea.eu.int/pdfs/ human/press/pr/12891805en.pdf. (accessed 24 July 2007).
2. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-339.
3. Volkers AC, Heerdink ER, van Dijk L. Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005). Pharmacoepidemiol Drug Saf 2007;16:1054-1062.
4. Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT. Psychotropic medication in children: a study from the Netherlands. Pediatrics 2001;108:E25.
5. Zito JM, Tobi H, de Jong-van den Berg LT et al. Antidepressant prevalence for youths: a multinational comparison. Pharmacoepidemiol Drug Saf 2006;15:793-798.
6. Murray ML, de Vries CS, Wong IC. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 2004;89:1098-1102.
7. Percudani M, Barbui C, Fortino I, Petrovich L. Worrying patterns of out-patient psychotropic drug prescribing in children and adolescents. Psychother Psychosom 2005;74:189-190.
8. Mancini J, Thirion X, Masut A et al. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. Pharmacoepidemiol Drug Saf 2006;15:494-503.
9. Clavenna A, Bonati M, Rossi E, De Rosa M. Increase in non-evidence based use of antidepressants in children is cause for concern. Br Med J 2004;328:711-712.
10. Bennett K, Teeling M, Feely J. Over-prescribing antidepressants to children: Pharmacoepidemiological study in primary care. Br Med J 2005;331:1451-1452.
11. Fegert JM, Kolch M, Zito JM, Glaeske G, Janhsen K. Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 2006;16:197-206.
12. Clavenna A, Rossi E, DeRosa M, Bonati M. Use of psychotropic medications in Italian children and adolescents. Eur J Pediatr 2007;166:339-347.
13. Murray ML, Thompson M, Santosh PJ, Wong IC. Effects of the committee on safety of medicines advice on antidepressant prescribing to children and adolescents in the UK. Drug Saf 2005;28: 1151-1157.
14. Rey ME, Tamarit L, Cruzado B. Children and adolescents selective serotonin reuptake inhibitors utilization in the Barcelona Healthcare Region, Spain. Gac Sanit 2006;20:167-168.
15. World Health Organization. The European Health Report 2005. Public health action for healthier children and population.
16. Delate T, Gelenberg AJ, Simmons VA, Motheral BR. Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatr Serv 2004;55: 387-391.
17. Bridge JA, Iyengar S, Salary CB et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007;297:1683-1696.
18. Geller DA, Biederman J, Stewart SE et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 2003;160:1919-1928.
19. American Academy Child Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. AACAP. J Am Acad Child Adolesc Psychiatry 1998;37:27S-45S.
20. Raz A. Perspectives on the efficacy of antdepressants for child and adolescent depression. PLoS Med 2006;3:e9.
21. Hazell P, O'Connell D, Heathcote D, Henry D. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 2002;CD002317.
22. Whittington CJ, Kendall T, Fonagy P et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-1345.
23. Moreno C, Arango C, Parellada M, Shaffer D, Bird H. Antidepressants in child and adolescent depression: where are the bugs? Acta Psychiatr Scand 2007;115:184-195.
24. Usala T, Clavenna A, Zuddas A, Bonati M. Randomised controlled trials of Selective Serotonin Reuptake Inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. Eur Neuropsychopharmacol. In press. 2007.
25. Safer DJ, Zito JM. Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents. J Child Adolesc Psychopharmacol 2006;16:159-169.
26. Casper RC, Fleisher BE, Lee-Ancajas JC et al.Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003;142:402-408.
27. Coyle JT. Psychotropic drug use in very young children. JAMA 2000;283:1059-1060.
28. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004;306:879-881.
29. Berard R, Fong R, Carpenter DJ, Thomason C, Wilkinson C. An international, multicenter, placebo- controlled trial of paroxetine in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 2006;16:59-75.
30. Emslie GJ, Wagner KD, Kutcher S et al. Paroxetine treatment in children and adolescents with major depressive disorder: A randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2006;45:709-719.
31. Kondro W, Sibbald B. Drug company experts advised staff to withhold data about SSRI use in children. CMAJ 2004;170:783.
32. Keller MB, Ryan ND, Strober M et al. Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-772.
33. Food and Drug Administration. FDA Talk Paper. FDA statement regarding the anti-depressant paxil for pediatric Population. http://www.fda.gov/ bbs/topics/ANSWERS/2003/ANS01230.html. (accessed 24 July 2007).
34. Waechter F. Paroxetine must not be given to patients under 18. BMJ 2003;326:1282.
35. Von Knorring AL, Olsson GI, Thomsen PH, Lemming OM, Hulten A. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. J Clin Psychopharmacol 2006;26:311-315.
36. Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006;45:280-288.
37. Kurian BT, Ray WA, Arbogast PG et al. Effect of regulatory warnings on antidepressant prescribing for children and adolescents. Arch Pediatr Adolesc Med 2007;161:690-696.
38. Bonati M. Epidemiologic evaluation of drug use in children. J Clin Pharmacol 1994;34:300-305.
39. ICH E11. Clinical investigation of medicinal products in the paediatric population. http://www.emea.europa.eu/pdfs/human/ich/271199en.pdf. (accessed 24 July 2007).